10x Genomics, Inc. — Director's Dealing 2020

Sep 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-09-01

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-01	Class A Common Stock	M	27692	$0.88	Acquired	95192	Direct
2020-09-01	Class A Common Stock	S	3400	$112.7336	Disposed	91792	Direct
2020-09-01	Class A Common Stock	S	12595	$113.6684	Disposed	79197	Direct
2020-09-01	Class A Common Stock	S	10049	$114.5487	Disposed	69148	Direct
2020-09-01	Class A Common Stock	S	1648	$115.3416	Disposed	67500	Direct
2020-09-02	Class A Common Stock	M	6058	$0.88	Acquired	73558	Direct
2020-09-02	Class A Common Stock	S	1900	$111.4037	Disposed	71658	Direct
2020-09-02	Class A Common Stock	S	2953	$112.0718	Disposed	68705	Direct
2020-09-02	Class A Common Stock	S	700	$112.9287	Disposed	68005	Direct
2020-09-02	Class A Common Stock	S	405	$114.0988	Disposed	67600	Direct
2020-09-02	Class A Common Stock	S	100	$114.90	Disposed	67500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Stock Option (right to buy)	$0.88	M	27692	Disposed	2025-10-27	Class A Common Stock (27692)	Direct
2020-09-02	Stock Option (right to buy)	$0.88	M	6058	Disposed	2025-10-27	Class A Common Stock (6058)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $112.07 to $113.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $113.07 to $114.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $114.07 to $115.06. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $115.11 to $115.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $110.76 to $111.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $111.76 to $112.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $112.76 to $113.07. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $113.82 to $114.38. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: All of the shares subject to the option are fully vested and exercisable as of the date hereof.